Scanner results now published to our DISCORD channel, Join Here: https://discord.gg/fTah76E3SE
« All Events
PR for PDUFA Info: https://www.businesswire.com/news/home/20220404005293/en/Alnylam-Announces-3-Month-Extension-of-Review-Period-for-New-Drug-Application-for-Vutrisiran